Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
J Med Chem ; 47(16): 3934-7, 2004 Jul 29.
Article in English | MEDLINE | ID: mdl-15267232

ABSTRACT

Glycogen synthase kinase-3 (GSK3) is involved in signaling from the insulin receptor. Inhibitors of GSK3 are expected to effect lowering of plasma glucose similar to insulin, making GSK3 an attractive target for the treatment of type 2 diabetes. Herein we report the discovery of a series of potent and selective GSK3 inhibitors. Compounds 7-12 show oral activity in an in vivo model of type II diabetes, and 9 and 12 have desirable PK properties.


Subject(s)
Glycogen Synthase Kinase 3/antagonists & inhibitors , Imidazoles/chemical synthesis , Pyridines/chemical synthesis , Pyrroles/chemical synthesis , Administration, Oral , Animals , Diabetes Mellitus, Type 2/drug therapy , Female , Glycogen Synthase Kinase 3 beta , Humans , Imidazoles/pharmacokinetics , Imidazoles/pharmacology , Pyridines/pharmacokinetics , Pyridines/pharmacology , Pyrroles/pharmacokinetics , Pyrroles/pharmacology , Rats , Rats, Zucker
SELECTION OF CITATIONS
SEARCH DETAIL
...